• In recent days, DNOW Inc. has faced pressure after disappointing fourth-quarter 2025 results, a significant loss, and the launch of a Rosen Law Firm investigation into potentially misleading business information, alongside a reduction in holdings by major shareholder Barrow Hanley Mewhinney & Strauss LLC.
• At the same time, DNOW is pursuing growth through its MRC Global deal and integration efforts, even as concerns mount over substandard operating margins, declining earnings per share and questions about whether recent investments are eroding returns on capital.
• We’ll now examine how the legal investigation and weak recent results could affect DNOW’s investment narrative and forward-looking risk profile.

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 19 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

DNOW Investment Narrative Recap

To own DNOW today, you have to believe that its enlarged distribution platform and MRC Global integration can eventually translate higher sales into healthier margins and sustainable profitability. The sharp fourth quarter 2025 loss and Rosen Law Firm’s investigation raise the near term focus on execution quality and disclosure practices, but they do not fundamentally change the core catalyst, which is whether the combined business can stop margin slippage and improve returns on capital.

The Rosen Law Firm class action inquiry is the announcement that most directly intersects with this catalyst, because it puts DNOW’s recent financial communication and loss-making quarter under a legal and reputational spotlight. For investors, it sits alongside concerns about substandard operating margins and eroding returns, sharpening attention on how the company accounts for integration costs, capital allocation and the benefits it expects from the MRC Global deal.

Yet against these growth ambitions, investors should be aware of the ongoing legal scrutiny around potentially misleading business information and how it could affect...

DNOW’s narrative projects $2.5 billion revenue and $61.4 million earnings by 2027. This implies revenue growth of 2.5% per year and an earnings decrease of $161.6 million from $223.0 million today.

Uncover how DNOW's forecasts yield a $16.00 fair value, a 40% upside to its current price.

Exploring Other Perspectives

Three members of the Simply Wall St Community place DNOW’s fair value between US$16.00 and about US$23.97, showing a wide spread of expectations. You can set those views against concerns that recent investments may be eroding returns on capital, which could weigh on how the market ultimately judges DNOW’s execution and resilience.

Explore 3 other fair value estimates on DNOW - why the stock might be worth over 2x more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your DNOW research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
• Our free DNOW research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate DNOW's overall financial health at a glance.

Want Some Alternatives?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• Capitalize on the AI infrastructure supercycle with our selection of the 35 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• We've uncovered the 14 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.